NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical trial NCT04332653 · COMPLETED

Trial details

NCT number: NCT04332653
Sponsor: NeoImmuneTech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Any Advanced Solid Tumors Triple Negative Breast Cancer Non Small Cell Lung Cancer Small Cell Lung Cancer Microsatellite Stable Colorectal Cancer Pancreatic Cancer Ovarian Cancer

Start date: 2020-06-10
Primary completion: 2024-11-22
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.